Mark Hillman's WST Position Overview
Mark Hillman (via Hillman Capital Management, Inc.) currently holds 8,906 shares of West Pharmaceutical Services, Inc. (WST) worth $2.45 M, representing 1.54% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Mark Hillman has initiated a new position in WST, representing a fresh investment thesis on this company. Largest reduction occurred in Q4 2025, reducing 1,367 shares.
Analysis based on 13F filings available since 2013 Q2
Mark Hillman's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Mark Hillman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1,367 | Reduce 13.31% | 8,906 | $275.14 |
| Q3 2025 | +10,273 | New Buy | 10,273 | $262.33 |
Mark Hillman's West Pharmaceutical Services Investment FAQs
Mark Hillman first purchased West Pharmaceutical Services, Inc. (WST) in Q3 2025, acquiring 10,273 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mark Hillman has held West Pharmaceutical Services, Inc. (WST) for 2 quarters since Q3 2025.
Mark Hillman's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q3 2025, adding 10,273 shares worth $2.69 M.
According to the latest 13F filing for Q4 2025, Mark Hillman's firm, Hillman Capital Management, Inc., owns 8,906 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $2.45 M.
As of the Q4 2025 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 1.54% of Mark Hillman's publicly disclosed stock portfolio, making it one of their key holdings.
Mark Hillman's peak holding in West Pharmaceutical Services, Inc. (WST) was 10,273 shares, as reported at the end of Q3 2025.